💥 Gate Square Event: #PostToWinCGN 💥
Post original content on Gate Square related to CGN, Launchpool, or CandyDrop, and get a chance to share 1,333 CGN rewards!
📅 Event Period: Oct 24, 2025, 10:00 – Nov 4, 2025, 16:00 UTC
📌 Related Campaigns:
Launchpool 👉 https://www.gate.com/announcements/article/47771
CandyDrop 👉 https://www.gate.com/announcements/article/47763
📌 How to Participate:
1️⃣ Post original content related to CGN or one of the above campaigns (Launchpool / CandyDrop).
2️⃣ Content must be at least 80 words.
3️⃣ Add the hashtag #PostToWinCGN
4️⃣ Include a screenshot s
AstraZeneca and Stone Pharmaceutical Group reach nearly $2 billion cardiovascular drug authorization protocol
On October 7th, Jin10 News reported that AstraZeneca and Chi-Med (01093.HK) have reached an exclusive licensing protocol to advance the development of a preclinical innovative small molecule lipoprotein(a) (Lp(a)) inhibitor to enhance the cardiovascular product pipeline. AstraZeneca said it will pay Chi-Med up to $1.92 billion in milestone and royalty payments and $100 million in upfront payment.